Alicia Zhang
- Oncology top 5%
- Pathology and Forensic Medicine top 5%
- Otorhinolaryngology top 2%
- Immunology
- Pulmonary and Respiratory Medicine
- Co-authors
- Ralf C. BargouMichael PfreundschuhNicole AdrianAndreas ViardotM. LibicherJulia StieglmaierDirk NagorsenGeorg Heß
- Topics
- CAR-T cell therapy research (9 papers)Acute Lymphoblastic Leukemia research (5 papers)Lymphoma Diagnosis and Treatment (5 papers)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Alicia Zhang
16 papers receiving 832 citations
Hit Papers
Peers
Comparison fields: 5 of 48
- Oncology 621
- Pathology and Forensic Medicine 293
- Otorhinolaryngology 160
- Immunology 158
- Pulmonary and Respiratory Medicine 156
Countries citing papers authored by Alicia Zhang
This map shows the geographic impact of Alicia Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alicia Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alicia Zhang more than expected).
Fields of papers citing papers by Alicia Zhang
This network shows the impact of papers produced by Alicia Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alicia Zhang. The network helps show where Alicia Zhang may publish in the future.
Co-authorship network of co-authors of Alicia Zhang
This figure shows the co-authorship network connecting the top 25 collaborators of Alicia Zhang. A scholar is included among the top collaborators of Alicia Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alicia Zhang. Alicia Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 7 | |
| 3 | 1 | |
| 4 | 61 | |
| 5 | 41 | |
| 6 | 1 | |
| 7 | 77 | |
| 8 | 17 | |
| 9 | 63 | |
| 10 | Phase 2 study of the bispecific T-cell engager (BiTE) antibody blinatumomab in relapsed/refractory diffuse large B-cell lymphomabreakdown → | 280 |
| 11 | 120 | |
| 12 | 113 | |
| 13 | 4 | |
| 14 | 21 | |
| 15 | 14 | |
| 16 | 26 |
About Alicia Zhang
Alicia Zhang is a scholar working on Otorhinolaryngology, Oncology and Pathology and Forensic Medicine, having authored 16 papers that have together received 851 indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Acute Lymphoblastic Leukemia research (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). The work is most often cited by research in Otorhinolaryngology (160 citations), Oncology (621 citations) and Pathology and Forensic Medicine (293 citations). Alicia Zhang has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Ralf C. Bargou, Michael Pfreundschuh, Nicole Adrian, Andreas Viardot, M. Libicher, Julia Stieglmaier, Dirk Nagorsen, Georg Heß, Svenja Neumann and Florian Zettl. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.